Compared to classical immunohistochemical markers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) which are routinely used for molecular classification and therapeutic decision making in breast cancer, COL11A1 exhibits a distinct biological and pathological profile. Here, ESR1 is linked to breast carcinoma.